Concepedia

Linu M. John

LM

Statistics

Publications

15

Citations

2.4K

H-Index

13

Active since

1998

Affiliations

Novo Nordisk (Denmark)(Current)

University of Copenhagen

The University of Texas at San Antonio Health Science Center

University of Zurich

University of Virginia

Linu M. John is an author at Novo Nordisk (Denmark) specializing in life sciences, endocrinology, and cell signaling.

ORCID

Publications per year

1998–2024

15

Publications

15

GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand

Linda Yang, Chih-Chuan Chang, Zhe Sun et al. · Nature Medicine · 2017 · 652 citations

, , +8

Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Ling Fu, Linu M. John, Sean H. Adams et al. · Endocrinology · 2004 · 566 citations

, , +12

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

Elizabeth Tomlinson, Ling Fu, Linu M. John et al. · Endocrinology · 2002 · 557 citations

, , +17

Differential Modulation of SERCA2 Isoforms by Calreticulin

Linu M. John, James D. Lechleiter, Patricia Camacho · The Journal of Cell Biology · 1998 · 212 citations · Full text

, , +13

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation

Helle Keinicke, Gao Sun, Caroline M. Junker Mentzel et al. · Endocrine Connections · 2020 · 98 citations · Full text

, , +16

1–5 of 15